Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

DGAP-Adhoc: Eckert & Ziegler to Increase Dividend Proposal


DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Forecast
Eckert & Ziegler to Increase Dividend Proposal

24-March-2022 / 19:16 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Berlin, March 24, 2022 - Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) closed fiscal year 2021 with sales of 180.4 million EUR (previous year: 176.1 million EUR) and net income of 34.5 EUR (previous year: 22.9 million EUR). Earnings per share amounted to EUR 1.67 (previous year: EUR 1.11). Based on these figures, the Executive Board and Supervisory Board today resolved to propose to the Annual General Meeting the payment of a dividend of EUR 0.50 (previous year: EUR 0.45) per dividend-bearing share.

For the current fiscal year 2022, the Executive Board expects an increase in sales to around EUR 200 million and a net income of around EUR 38 million. The forecast is based on a weighted average exchange rate of USD 1.20 per EUR and is subject to the assumption that no major disruptions continue to result from the developments in Ukraine.

The detailed financial statements for 2021 will be published on March 30, 2022.

For enquiries please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com


24-March-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1311583

 
End of Announcement DGAP News Service

1311583  24-March-2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1311583&application_name=news&site_id=sharewise

Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie

46,56 €
-0,56 %
Ein geringer Kursrückgang bei Eckert & Ziegler Strahlen- und Medizintechnik AG heute, um -0,56 %.
Positive Stimmung für Eckert & Ziegler Strahlen- und Medizintechnik AG mit mehreren Buy-Einschätzungen, keine Sell-Einschätzungen.
Bei einem Kursziel von 95 € für Eckert & Ziegler Strahlen- und Medizintechnik AG könnte der aktuelle Kurs von 46.56 € mehr als verdoppelt werden.
Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare